The investigators expect to find higher levels of both classical and minor antiphospholipid (APL) antibodies among the stroke cases. Furthermore, the investigators expect to find not only classical APLA but also minor antibodies.
The investigators believe that minor antibodies have a major role in the hypercoagulability state.
- Observation: Case Control
- Perspective: Prospective
- Sampling: Non-Probability Sample
on a bank of 207 stroke patients serum samples, and also on 40 healthy controls. The samples were collected during the acute phase of the ischemic event.
|Type||Measure||Time Frame||Safety Issue|
|No outcomes associated with this trial.|
Biospecimen Retention:Samples Without DNA - Serum samples of Stroke patients withdrawned within 36 hrs since stroke evoked. Healthy controls